-
-
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-05-07 Mark W Tenforde,Samantha M Olson,Wesley H Self,H Keipp Talbot,Christopher J Lindsell,Jay S Steingrub,Nathan I Shapiro,Adit A Ginde,David J Douin,Matthew E Prekker,Samuel M Brown,Ithan D Peltan,Michelle N Gong,Amira Mohamed,Akram Khan,Matthew C Exline,D Clark Files,Kevin W Gibbs,William B Stubblefield,Jonathan D Casey,Todd W Rice,Carlos G Grijalva,David N Hager,Arber Shehu,Nida Qadir,Steven Y Chang
Adults aged ≥65 years are at increased risk for severe outcomes from COVID-19 and were identified as a priority group to receive the first COVID-19 vaccines approved for use under an Emergency Use Authorization (EUA) in the United States (1-3). In an evaluation at 24 hospitals in 14 states,* the effectiveness of partial or full vaccination† with Pfizer-BioNTech or Moderna vaccines against COVID-19-associated
-
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-05-07 Anne M Hause,Julianne Gee,Tara Johnson,Amelia Jazwa,Paige Marquez,Elaine Miller,John Su,Tom T Shimabukuro,David K Shay
On April 7, 2021, after 5 weeks' use of the Janssen COVID-19 vaccine under the Food and Drug Administration (FDA) Emergency Use Authorization (EUA), CDC received reports of clusters of anxiety-related events after administration of Janssen COVID-19 vaccine from five mass vaccination sites, all in different states. To further investigate these cases, CDC interviewed vaccination site staff members to
-
Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2019-2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-05-07 Jude N Tuma,Amanda L Wilkinson,Ousmane M Diop,Jaume Jorba,Tracie Gardner,Cynthia J Snider,Abhijeet Anand,Jamal Ahmed
When the Global Polio Eradication Initiative (GPEI) was established in 1988, an estimated 350,000 poliomyelitis cases were reported worldwide. In 2020, 140 wild poliovirus (WPV) cases were confirmed, representing a 99.99% reduction since 1988. WPV type 1 transmission remains endemic in only two countries (Pakistan and Afghanistan), but outbreaks of circulating vaccine-derived poliovirus (cVDPV) occurred
-
-
Notes from the Field: An Outbreak of Escherichia coli O157:H7 Infections Linked to Romaine Lettuce Exposure - United States, 2019. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-05-07 Connor Hoff,Jeffrey Higa,Kane Patel,Ellen Gee,Allison Wellman,Jeff Vidanes,April Holland,Varvara Kozyreva,Jonathan Zhu,Mia Mattioli,Alexis Roundtree,Kenai McFadden,Laura Whitlock,Matthew Wise,Laura Gieraltowski,Colin Schwensohn
-
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-30 Jessica R MacNeil,John R Su,Karen R Broder,Alice Y Guh,Julia W Gargano,Megan Wallace,Stephen C Hadler,Heather M Scobie,Amy E Blain,Danielle Moulia,Matthew F Daley,Veronica V McNally,José R Romero,H Keipp Talbot,Grace M Lee,Beth P Bell,Sara E Oliver
On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Janssen COVID-19 (Ad.26.COV2.S) vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical company, Johnson & Johnson; New Brunswick, New Jersey), and on February 28, 2021, the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations for its use in persons aged ≥18
-
COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-30 Alyson M Cavanaugh,Sarah Fortier,Patricia Lewis,Vaneet Arora,Matt Johnson,Karim George,Joshua Tobias,Stephanie Lunn,Taylor Miller,Douglas Thoroughman,Kevin B Spicer
Although COVID-19 mRNA vaccines demonstrated high efficacy in clinical trials (1), they were not 100% efficacious. Thus, some infections postvaccination are expected. Limited data are available on effectiveness in skilled nursing facilities (SNFs) and against emerging variants. The Kentucky Department for Public Health (KDPH) and a local health department investigated a COVID-19 outbreak in a SNF that
-
COVID-19 Outbreak Among Farmworkers - Okanogan County, Washington, May-August 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-30 James S Miller,Michelle Holshue,Tia K H Dostal,Laura P Newman,Scott Lindquist
Okanogan County, Washington, experienced increased community transmission of SARS-CoV-2, the virus that causes COVID-19, during summer 2020 (1). Multiple COVID-19 outbreaks occurred in agricultural settings, including a large outbreak among employees of a fruit grower during May-August. Because of this outbreak, Okanogan County Public Health and the Washington State Department of Health initiated one-time
-
Emergency Department Visits for Tick Bites - United States, January 2017-December 2019. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-30 Grace E Marx,Melanie Spillane,Alyssa Beck,Zachary Stein,Aaron Kite Powell,Alison F Hinckley
The incidence of tickborne diseases in the United States is increasing; reported cases more than doubled from >22,000 in 2004 to >48,000 in 2016 (1). Ticks are responsible for approximately 95% of all locally acquired vectorborne diseases reported by states and the District of Columbia, with Lyme disease accounting for >80% of those cases (2). After a tick bite, persons might seek care at an emergency
-
-
-
Notes from the Field: Update on Excess Deaths Associated with the COVID-19 Pandemic - United States, January 26, 2020-February 27, 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-16 Lauren M Rossen,Amy M Branum,Farida B Ahmad,Paul D Sutton,Robert N Anderson
-
Progress in Immunization Safety Monitoring - Worldwide, 2010-2019. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-16 Omar Salman,Katherine Topf,Rebecca Chandler,Laura Conklin
High levels of coverage with safe and effective immunizations are critical to the successful control and prevention of vaccine-preventable diseases worldwide. In addition to stringent standards to regulate the safety of vaccines, robust postlicensure monitoring systems help ensure that the benefits of vaccines continue to outweigh the risks for the populations who receive them. National Expanded Programmes
-
Factors Associated with Participation in Elementary School-Based SARS-CoV-2 Testing - Salt Lake County, Utah, December 2020-January 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-16 Nathaniel M Lewis,Rebecca B Hershow,Victoria T Chu,Karen Wu,Alison T Milne,Nathan LaCross,Mary Hill,Ilene Risk,Adam L Hersh,Hannah L Kirking,Jacqueline E Tate,Snigdha Vallabhaneni,Angela C Dunn
During December 3, 2020-January 31, 2021, CDC, in collaboration with the University of Utah Health and Economic Recovery Outreach Project,* Utah Department of Health (UDOH), Salt Lake County Health Department, and one Salt Lake county school district, offered free, in-school, real-time reverse transcription-polymerase chain reaction (RT-PCR) saliva testing as part of a transmission investigation of
-
Emergency Department Visits for COVID-19 by Race and Ethnicity - 13 States, October-December 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-16 Amanda R Smith,Jourdan DeVies,Elise Caruso,Lakshmi Radhakrishnan,Michael Sheppard,Zachary Stein,Renee M Calanan,Kathleen P Hartnett,Aaron Kite-Powell,Loren Rodgers,Jennifer Adjemian
Hispanic or Latino (Hispanic), non-Hispanic Black or African American (Black), and non-Hispanic American Indian or Alaska Native (AI/AN) persons have experienced disproportionately higher rates of hospitalization and death attributable to COVID-19 than have non-Hispanic White (White) persons (1-4). Emergency care data offer insight into COVID-19 incidence; however, differences in use of emergency department
-
QuickStats: Age-Adjusted Percentage* of Adults Aged 25-64 Years Who Are Very Worried About Their Ability to Pay Medical Bills if They Get Sick or Have an Accident,† by Sex and Veteran Status - National Health Interview Survey, United States, 2019§. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-16
-
-
Provisional Mortality Data - United States, 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-09 Farida B Ahmad,Jodi A Cisewski,Arialdi Miniño,Robert N Anderson
CDC's National Vital Statistics System (NVSS) collects and reports annual mortality statistics using data from U.S. death certificates. Because of the time needed to investigate certain causes of death and to process and review data, final annual mortality data for a given year are typically released 11 months after the end of the calendar year. Daily totals reported by CDC COVID-19 case surveillance
-
-
COVID-19 Incidence and Mortality Among American Indian/Alaska Native and White Persons - Montana, March 13-November 30, 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-09 Laura L Williamson,Todd S Harwell,Todd M Koch,Stacey L Anderson,Magdalena K Scott,James S Murphy,Greg S Holzman,Helen F Tesfai
Geographic differences in infectious disease mortality rates have been observed among American Indian or Alaska Native (AI/AN) persons in the United States (1), and aggregate analyses of data from selected U.S. states indicate that COVID-19 incidence and mortality are higher among AI/AN persons than they are among White persons (2,3). State-level data could be used to identify disparities and guide
-
Use of Stay-at-Home Orders and Mask Mandates to Control COVID-19 Transmission - Blackfeet Tribal Reservation, Montana, June-December 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-09 Caroline Q Pratt,Anna N Chard,Rosaula LaPine,K Webb Galbreath,Cinnamon Crawford,Albert Plant,Garland Stiffarm,Neil Sun Rhodes,Lorissa Hannon,Thu-Ha Dinh
COVID-19 has disproportionately affected persons who identify as non-Hispanic American Indian or Alaska Native (AI/AN) (1). The Blackfeet Tribal Reservation, the northern Montana home of the sovereign Blackfeet Nation, with an estimated population of 10,629 (2), detected the first COVID-19 case in the community on June 16, 2020. Following CDC guidance,* and with free testing widely available, the Indian
-
Notes from the Field: COVID-19 Case Investigation and Contact Tracing Program - Spirit Lake Tribe, North Dakota, September-November 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-09 James Matthias,Tracy Charboneau,Cheri Schaffer,Jennifer Rusten,Sharon Whitmer,Joseph de la Paz,Janet Dykstra,Ishani Pathmanathan,Daniel Stowell
-
-
Death Certificate-Based ICD-10 Diagnosis Codes for COVID-19 Mortality Surveillance - United States, January-December 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-09 Adi V Gundlapalli,Amy M Lavery,Tegan K Boehmer,Michael J Beach,Henry T Walke,Paul D Sutton,Robert N Anderson
Approximately 375,000 deaths during 2020 were attributed to COVID-19 on death certificates reported to CDC (1). Concerns have been raised that some deaths are being improperly attributed to COVID-19 (2). Analysis of International Classification of Diseases, Tenth Revision (ICD-10) diagnoses on official death certificates might provide an expedient and efficient method to demonstrate whether reported
-
Community Transmission of SARS-CoV-2 Associated with a Local Bar Opening Event - Illinois, February 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-09 Samira Sami,Caitlin R Turbyfill,Shelby Daniel-Wayman,Stacy Shonkwiler,Kiva A Fisher,Macey Kuhring,Aaron M Patrick,Stephanie Hinton,Amanda S Minor,Jessica N Ricaldi,Ngozi Ezike,Judy Kauerauf,Wayne A Duffus
During February 2021, an opening event was held indoors at a rural Illinois bar that accommodates approximately 100 persons. The Illinois Department of Public Health (IDPH) and local health department staff members investigated a COVID-19 outbreak associated with this opening event. Overall, 46 COVID-19 cases were linked to the event, including cases in 26 patrons and three staff members who attended
-
Use of Real-Time PCR for Chlamydia psittaci Detection in Human Specimens During an Outbreak of Psittacosis - Georgia and Virginia, 2018. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-09 Olivia L McGovern,Miwako Kobayashi,Kelly A Shaw,Christine Szablewski,Julie Gabel,Caroline Holsinger,Cherie Drenzek,Skyler Brennan,Jennifer Milucky,Jennifer L Farrar,Bernard J Wolff,Alvaro J Benitez,Kathleen A Thurman,Maureen H Diaz,Jonas M Winchell,Stephanie Schrag
Psittacosis is typically a mild febrile respiratory illness caused by infection with the bacterium Chlamydia psittaci and usually transmitted to humans by infected birds (1). On average, 11 psittacosis cases per year were reported in the United States during 2000-2017. During August-October 2018, the largest U.S. psittacosis outbreak in 30 years (82 cases identified*) occurred in two poultry slaughter
-
-
Community-Associated Outbreak of COVID-19 in a Correctional Facility - Utah, September 2020-January 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-02 Nathaniel M Lewis,Amelia Prebish Salmanson,Andrea Price,Ilene Risk,Colleen Guymon,Marcus Wisner,Kyle Gardner,Rena Fukunaga,Amee Schwitters,Lauren Lambert,Henry C Baggett,Raimi Ewetola,Angela C Dunn
Transmission of SARS-CoV-2, the virus that causes COVID-19, is common in congregate settings such as correctional and detention facilities (1-3). On September 17, 2020, a Utah correctional facility (facility A) received a report of laboratory-confirmed SARS-CoV-2 infection in a dental health care provider (DHCP) who had treated incarcerated persons at facility A on September 14, 2020 while asymptomatic
-
-
Counties with High COVID-19 Incidence and Relatively Large Racial and Ethnic Minority Populations - United States, April 1-December 22, 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-02 Florence C Lee,Laura Adams,Sierra J Graves,Greta M Massetti,Renee M Calanan,Ana Penman-Aguilar,S Jane Henley,Francis B Annor,Michelle Van Handel,Noah Aleshire,Tonji Durant,Jennifer Fuld,Sean Griffing,Laura Mattocks,Leandris Liburd
Long-standing systemic social, economic, and environmental inequities in the United States have put many communities of color (racial and ethnic minority groups) at increased risk for exposure to and infection with SARS-CoV-2, the virus that causes COVID-19, as well as more severe COVID-19-related outcomes (1-3). Because race and ethnicity are missing for a proportion of reported COVID-19 cases, counties
-
Rapid Spread of SARS-CoV-2 in a State Prison After Introduction by Newly Transferred Incarcerated Persons - Wisconsin, August 14-October 22, 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-02 Rebecca B Hershow,Hannah E Segaloff,Abigail C Shockey,Kelsey R Florek,Sabrina K Murphy,Weston DuBose,Tammy L Schaeffer,Jo Anna Powell Mph,Krystal Gayle,Lauren Lambert,Amee Schwitters,Kristie E N Clarke,Ryan Westergaard
SARS-CoV-2, the virus that causes COVID-19, can spread rapidly in prisons and can be introduced by staff members and newly transferred incarcerated persons (1,2). On September 28, 2020, the Wisconsin Department of Health Services (DHS) contacted CDC to report a COVID-19 outbreak in a state prison (prison A). During October 6-20, a CDC team investigated the outbreak, which began with 12 cases detected
-
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-02 Mark G Thompson,Jefferey L Burgess,Allison L Naleway,Harmony L Tyner,Sarang K Yoon,Jennifer Meece,Lauren E W Olsho,Alberto J Caban-Martinez,Ashley Fowlkes,Karen Lutrick,Jennifer L Kuntz,Kayan Dunnigan,Marilyn J Odean,Kurt T Hegmann,Elisha Stefanski,Laura J Edwards,Natasha Schaefer-Solle,Lauren Grant,Katherine Ellingson,Holly C Groom,Tnelda Zunie,Matthew S Thiese,Lynn Ivacic,Meredith G Wesley,Julie
Messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) COVID-19 vaccines have been shown to be effective in preventing symptomatic COVID-19 in randomized placebo-controlled Phase III trials (1,2); however, the benefits of these vaccines for preventing asymptomatic and symptomatic SARS-CoV-2 (the virus that causes COVID-19) infection, particularly when administered in real-world conditions
-
Use of Selected Recommended Clinical Preventive Services - Behavioral Risk Factor Surveillance System, United States, 2018. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-02 Suhang Song,Allison White,James E Kucik
Clinical preventive services play an important role in preventing deaths, and Healthy People 2020 has set national goals for using clinical preventive services to improve population health (1). The Patient Protection and Affordable Care Act (ACA) requires many health plans to cover certain recommended clinical preventive services without cost-sharing when provided in-network (covered clinical preventive
-
Symptoms of Anxiety or Depressive Disorder and Use of Mental Health Care Among Adults During the COVID-19 Pandemic - United States, August 2020-February 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-02 Anjel Vahratian,Stephen J Blumberg,Emily P Terlizzi,Jeannine S Schiller
The spread of disease and increase in deaths during large outbreaks of transmissible diseases is often associated with fear and grief (1). Social restrictions, limits on operating nonessential businesses, and other measures to reduce pandemic-related mortality and morbidity can lead to isolation and unemployment or underemployment, further increasing the risk for mental health problems (2). To rapidly
-
Willingness to Receive a COVID-19 Vaccination Among Incarcerated or Detained Persons in Correctional and Detention Facilities - Four States, September-December 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-04-02 Marc F Stern,Alexandra M Piasecki,Lara B Strick,Poornima Rajeshwar,Erika Tyagi,Sharon Dolovich,Priti R Patel,Rena Fukunaga,Nathan W Furukawa
Incarcerated and detained persons are at increased risk for acquiring COVID-19. However, little is known about their willingness to receive a COVID-19 vaccination. During September-December 2020, residents in three prisons and 13 jails in four states were surveyed regarding their willingness to receive a COVID-19 vaccination and their reasons for COVID-19 vaccination hesitancy or refusal. Among 5,110
-
-
-
County-Level COVID-19 Vaccination Coverage and Social Vulnerability - United States, December 14, 2020-March 1, 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-26 Michelle M Hughes,Alice Wang,Marissa K Grossman,Eugene Pun,Ari Whiteman,Li Deng,Elaine Hallisey,J Danielle Sharpe,Emily N Ussery,Shannon Stokley,Trieste Musial,Daniel L Weller,Bhavini Patel Murthy,Laura Reynolds,Lynn Gibbs-Scharf,LaTreace Harris,Matt D Ritchey,Robin L Toblin
The U.S. COVID-19 vaccination program began in December 2020, and ensuring equitable COVID-19 vaccine access remains a national priority.* COVID-19 has disproportionately affected racial/ethnic minority groups and those who are economically and socially disadvantaged (1,2). Thus, achieving not just vaccine equality (i.e., similar allocation of vaccine supply proportional to its population across jurisdictions)
-
COVID-19 in Primary and Secondary School Settings During the First Semester of School Reopening - Florida, August-December 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-26 Timothy Doyle,Katherine Kendrick,Thomas Troelstrup,Megan Gumke,Jerri Edwards,Shay Chapman,Randy Propper,Scott A Rivkees,Carina Blackmore
After detection of cases of COVID-19 in Florida in March 2020, the governor declared a state of emergency on March 9,* and all school districts in the state suspended in-person instruction by March 20. Most kindergarten through grade 12 (K-12) public and private schools in Florida reopened for in-person learning during August 2020, with varying options for remote learning offered by school districts
-
Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies - St. Louis County and City of Springfield, Missouri, December 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-26 Patrick Dawson,Mary Claire Worrell,Sara Malone,Sarah C Tinker,Stephanie Fritz,Brett Maricque,Sadaf Junaidi,Gemille Purnell,Albert M Lai,Julie A Neidich,Justin S Lee,Rachel C Orscheln,Rachel Charney,Terri Rebmann,Jon Mooney,Nancy Yoon,Machelle Petit,Spring Schmidt,Jean Grabeel,Lee Ann Neill,Lisa C Barrios,Snigdha Vallabhaneni,Randall W Williams,Clay Goddard,Jason G Newland,John C Neatherlin,Johanna
Many kindergarten through grade 12 (K-12) schools offering in-person learning have adopted strategies to limit the spread of SARS-CoV-2, the virus that causes COVID-19 (1). These measures include mandating use of face masks, physical distancing in classrooms, increasing ventilation with outdoor air, identification of close contacts,* and following CDC isolation and quarantine guidance† (2). A 2-week
-
Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets - Worldwide, 2019. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-26 Rena Fukunaga,Philippe Glaziou,Jennifer B Harris,Anand Date,Katherine Floyd,Tereza Kasaeva
Although tuberculosis (TB) is curable and preventable, in 2019, TB remained the leading cause of death from a single infectious agent worldwide and the leading cause of death among persons living with HIV infection (1). The World Health Organization's (WHO's) End TB Strategy set ambitious targets for 2020, including a 20% reduction in TB incidence and a 35% reduction in the number of TB deaths compared
-
Tuberculosis - United States, 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-26 Molly Deutsch-Feldman,Robert H Pratt,Sandy F Price,Clarisse A Tsang,Julie L Self
Tuberculosis (TB) disease incidence has decreased steadily since 1993 (1), a result of decades of work by local TB programs to detect, treat, and prevent TB disease and transmission. During 2020, a total of 7,163 TB cases were provisionally reported to CDC's National Tuberculosis Surveillance System (NTSS) by the 50 U.S. states and the District of Columbia (DC), a relative reduction of 20%, compared
-
QuickStats: Age-Adjusted Death Rates* for Motor Vehicle Traffic Injury† - United States, 2019. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-19
-
Minimal SARS-CoV-2 Transmission After Implementation of a Comprehensive Mitigation Strategy at a School - New Jersey, August 20-November 27, 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-19 Kevin G Volpp,Bruce H Kraut,Smita Ghosh,John Neatherlin
During fall 2020, many U.S. kindergarten through grade 12 (K-12) schools closed campuses and instituted remote learning to limit in-school transmission of SARS-CoV-2, the virus that causes COVID-19 (1,2). A New Jersey grade 9-12 boarding school with 520 full-time resident students, 255 commuter students, and 405 faculty and staff members implemented a comprehensive mitigation strategy that included
-
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-19 Amadea Britton,Kara M Jacobs Slifka,Chris Edens,Srinivas Acharya Nanduri,Stephen M Bart,Nong Shang,Adora Harizaj,Jillian Armstrong,Kerui Xu,Hanna Y Ehrlich,Elizabeth Soda,Gordana Derado,Jennifer R Verani,Stephanie J Schrag,John A Jernigan,Vivian H Leung,Sunil Parikh
Residents of long-term care facilities (LTCFs), particularly those in skilled nursing facilities (SNFs), have experienced disproportionately high levels of COVID-19-associated morbidity and mortality and were prioritized for early COVID-19 vaccination (1,2). However, this group was not included in COVID-19 vaccine clinical trials, and limited postauthorization vaccine effectiveness (VE) data are available
-
-
Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-12 Moriam Ojelade,Annette Rodriguez,Dante Gonzalez,Denzel Otokunrin,Srikanth Ramachandruni,Elizabeth Cuevas,Kelly Moon,Carla Gutiérrez Tyler,Melissa Freeland,Mark Anderson,Kambria Haire,Yuridia Orozco,Fija Scipio,Yuri Springer,Emilie Prot,Jennifer A Shuford
In December 2020, the B.1.1.7 genetic variant of SARS-CoV-2, the virus that causes COVID-19, was first reported after emergence and rapid circulation in the United Kingdom (1). Evidence suggests that the B.1.1.7 variant is more efficiently transmitted than are other SARS-CoV-2 variants, and widespread circulation could thereby increase SARS-CoV-2 infection and hospitalization rates (1,2). The first
-
First Identified Cases of SARS-CoV-2 Variant P.1 in the United States - Minnesota, January 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-12 Melanie J Firestone,Alexandra J Lorentz,Stephanie Meyer,Xiong Wang,Kathryn Como-Sabetti,Sara Vetter,Kirk Smith,Stacy Holzbauer,Amanda Beaudoin,Jacob Garfin,Kristin Ehresmann,Richard Danila,Ruth Lynfield
Since December 2020, the Minnesota Department of Health (MDH) Public Health Laboratory has been receiving 100 specimens per week (50 from each of two clinical partners) with low cycle threshold (Ct) values for routine surveillance for SARS-CoV-2, the virus that causes COVID-19. On January 25, 2021, MDH identified the SARS-CoV-2 variant P.1 in one specimen through this surveillance system using whole
-
Screening for HIV Among Patients at Tuberculosis Clinics - Results from Population-Based HIV Impact Assessment Surveys, Malawi, Zambia, and Zimbabwe, 2015-2016. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-12 Nikhil Kothegal,Alice Wang,Sasi Jonnalagadda,Adam MacNeil,Elizabeth Radin,Kristin Brown,Owen Mugurungi,Regis Choto,Shirish Balachandra,John H Rogers,Godfrey Musuka,Thokozani Kalua,Michael Odo,Andrew Auld,Laurence Gunde,Evelyn Kim,Danielle Payne,Patrick Lungu,Lloyd Mulenga,Ahmed Saadani Hassani,Tepa Nkumbula,Hetal Patel,Bharat Parekh,Andrew C Voetsch
The World Health Organization and national guidelines recommend HIV testing and counseling at tuberculosis (TB) clinics for all patients, regardless of TB diagnosis (1). Population-based HIV Impact Assessment (PHIA) survey data for 2015-2016 in Malawi, Zambia, and Zimbabwe were analyzed to assess HIV screening at TB clinics among persons who had positive HIV test results in the survey. The analysis
-
Health Care Utilization and Outcomes Associated with Accidental Poisonous Mushroom Ingestions - United States, 2016-2018. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-12 Jeremy A W Gold,Emily Kiernan,Michael Yeh,Brendan R Jackson,Kaitlin Benedict
Accidental consumption of poisonous mushrooms can result in serious illness and death (1). Reports of severe poisonings from consumption of foraged mushrooms for food or hallucinogenic purposes increased during 1999-2016 (2), and approximately 7,500 poisonous mushroom ingestions were reported annually to poison control centers across the United States (1). To estimate the frequency of emergency department
-
Association of State-Issued Mask Mandates and Allowing On-Premises Restaurant Dining with County-Level COVID-19 Case and Death Growth Rates - United States, March 1-December 31, 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-12 Gery P Guy,Florence C Lee,Gregory Sunshine,Russell McCord,Mara Howard-Williams,Lyudmyla Kompaniyets,Christopher Dunphy,Maxim Gakh,Regen Weber,Erin Sauber-Schatz,John D Omura,Greta M Massetti,,
CDC recommends a combination of evidence-based strategies to reduce transmission of SARS-CoV-2, the virus that causes COVID-19 (1). Because the virus is transmitted predominantly by inhaling respiratory droplets from infected persons, universal mask use can help reduce transmission (1). Starting in April, 39 states and the District of Columbia (DC) issued mask mandates in 2020. Reducing person-to-person
-
Reduction in COVID-19 Patients Requiring Mechanical Ventilation Following Implementation of a National COVID-19 Vaccination Program - Israel, December 2020-February 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-05 Ehud Rinott,Ilan Youngster,Yair E Lewis
-
Community Transmission of SARS-CoV-2 at Three Fitness Facilities - Hawaii, June-July 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-05 Laura M Groves,Lauren Usagawa,Joe Elm,Eleanor Low,Augustina Manuzak,Joshua Quint,Katherine E Center,Ann M Buff,Sarah K Kemble
-
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-05 Sara E Oliver,Julia W Gargano,Heather Scobie,Megan Wallace,Stephen C Hadler,Jessica Leung,Amy E Blain,Nancy McClung,Doug Campos-Outcalt,Rebecca L Morgan,Sarah Mbaeyi,Jessica MacNeil,José R Romero,H Keipp Talbot,Grace M Lee,Beth P Bell,Kathleen Dooling
-
COVID-19 Outbreak Among Attendees of an Exercise Facility - Chicago, Illinois, August-September 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-03-05 Frances R Lendacki,Richard A Teran,Stephanie Gretsch,Marielle J Fricchione,Janna L Kerins
-
-
First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2021-02-26 Julianne Gee,Paige Marquez,John Su,Geoffrey M Calvert,Ruiling Liu,Tanya Myers,Narayan Nair,Stacey Martin,Thomas Clark,Lauri Markowitz,Nicole Lindsey,Bicheng Zhang,Charles Licata,Amelia Jazwa,Mark Sotir,Tom Shimabukuro
Two coronavirus disease 2019 (COVID-19) vaccines are currently authorized for use in the United States. The Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine on December 11, 2020, and for the Moderna COVID-19 vaccine on December 18, 2020; each is administered as a 2-dose series. The Advisory Committee on Immunization Practices issued
-
-